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Abstract.
Background: Whilst changes in the frequency of subthalamic deep brain stimulation (STN-DBS) have been proposed to
improve control of tremor or axial motor features in Parkinson’s disease (PD), little is known about the effects of frequency
changes on upper limb motor function, particularly bradykinesia.
Objective: To investigate the acute effects of various STN-DBS frequencies (40–160 Hz, 40 Hz intervals) on upper limb
motor function.
Methods: We carried out a randomised, double-blind study on 20 PD patients with chronic STN-DBS using the Simple and
Assembly components of the Purdue Pegboard (PP) test and a modified upper limb version of the UPDRS-III (UL-UPDRS-III).
Results: There was no significant effect of frequency on bradykinesia on the Simple PP task or the UL-UPDRS-III. There
was an effect of frequency on the Assembly PP score when comparing all frequencies (p = 0.019) and between 80 Hz and
130 Hz (p = 0.007), with lower frequencies yielding a better performance. Rigidity and Tremor scores were significantly
reduced with higher (>80 Hz) compared to lower (40 Hz) frequencies.
Conclusions: Our findings suggest that a wide range of frequencies are efficacious in improving acute upper-limb motor
function. Reducing the frequency of stimulation down to 80 Hz is safe and has a similar clinical effect to higher frequencies.
Therefore, a wider range of frequencies are available when it comes adjusting patients’ acute settings without the risk of
worsening bradykinesia.
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INTRODUCTION
Deep brain stimulation of the subthalamic nucleus
(STN-DBS) has been an established therapy for
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over 20 years in advanced Parkinson’s disease (PD)
patients who have developed fluctuations in the motor
response to levodopa-based therapy and can produce
a dramatic improvement in cardinal PD symptoms
[1, 2]. The electrical parameters for DBS systems
have largely been empirically derived [3]. However,
one double-blind study in which frequency, volt-
age and pulse width were systematically manipulated
found that voltage had the greatest influence on motor
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symptoms and that voltages ≥3 V and frequencies
≥130 Hz led to the greatest symptomatic improve-
ment in PD patients [4], supporting current clinical
practice.
Nevertheless, high frequency (HFS, defined as fre-
quency >100 Hz) DBS can lead to notable side effects
largely axial in nature, such as gait freezing, swal-
lowing disturbance and decreased verbal fluency [5].
Low frequency stimulation (LFS, <100 Hz) can also
benefit axial motor symptoms [6], but its effects on
limb motor function have not been systematically
assessed. Therefore, we sought to investigate the
effect of STN-DBS frequency on upper limb motor
function in general, and limb bradykinesia in particu-
lar. We carried out a randomised, double-blind study
to assess how frequencies ranging from 40–160 Hz in
40 Hz intervals, affected relief of these PD symptoms
in the acute setting.
METHODS
20 patients with idiopathic PD (as defined per
the United Kingdom Brain Bank Criteria) with
chronic bilateral STN-DBS stimulation (>6 months)
were selected for the study. The study protocol
was approved by the local ethics committee and all
participants gave informed written consent as per
the declaration of Helsinki. Inclusion criteria were
applied to PD patients with chronic STN-DBS as
follows: 1) Participants were cognitively competent
based on Mini-Mental State Examination (MMSE)
>24 and frontal assessment battery (FAB) >12; 2)
Motor symptoms of PD (for instance, tremor) were
not severe enough to completely compromise task
performance; 3) There was no acute concomitant dis-
ease and no other neurological conditions.
Participants were assessed OFF-medication fol-
lowing at least 12 hours of medication withdrawal
overnight. After an assessment at the partici-
pants’ baseline frequency (130 Hz), frequencies from
40–160 Hz in 40 Hz intervals were used, with the
order of frequencies randomised using a random
number generator. Each participant served as his/her
own control. Both the participant and examiner (SM)
were blinded to the frequencies. For each trial, a neu-
rologist with expertise in movement disorders (AZ,
DG, or PM) programmed the frequency at least 10
minutes before reassessment; we felt this interval to
be an appropriate compromise between being able
to assess for a meaningful clinical effect in the new
frequency whilst minimising the length of any sig-
nificantly discomforting or intolerable side-effects.
The Total Electrical Energy Delivered (TEED) was
kept constant at the baseline level across frequen-
cies by adjusting the voltage using an established
formula [7].
Experimental tasks
In order to minimise the burden of assessment, we
decided to focus on assessing upper limb function,
given that it is the standard method of assessing the
clinical effect of DBS [8]. Two validated tasks were
used to assess upper limb motor function, particu-
larly bradykinesia: the Purdue Pegboard task (PP)
[9] and a modified Unified PD Rating Scale motor
scale including all items concerning upper limb motor
function (UL-UPDRS-III). For the PP, both the Sim-
ple and Assembly tasks were used; in the Simple
task, participants were scored on the number of
pegs placed into the pegboard in 30 seconds, with
left hand, right hand and then both hands. In the
Assembly task, participants assembled a peg sequen-
tially with four components using both hands, and
were scored by the number of pegs fully assembled
(1 point) and the number of partially assembled pegs
in the correct sequence (0.5 points). Participants were
permitted to briefly practise the tasks beforehand
for familiarisation. The UL-UPDRS-III comprised
measures of upper body motor function: distal limb
bradykinesia (items 23–25, 6 measures), rest tremor
(item 20, 3 measures) and rigidity (item 22, 3 mea-
sures), which were summated into subscales. Each
parameter was scored from 0 (normal) to 4 (severe).
Examinations were videotaped and UL-UPDRS-III
scores were subsequently rated by a separate neu-
rologist blinded to stimulation frequencies (AZ, DG,
or PM).
Statistical analysis
Statistical analysis was carried out using R 3.2.1.
[10] Where the data set was normally distributed
(assessed by Shapiro-Wilk test), analysis of variance
(ANOVA) and paired t-tests were used. If data were
non-normally distributed, the Kruskal-Wallis test and
Wilcoxon Signed Rank Test were used. All data was
analysed for significance at the <0.05 level. Analy-
ses were made to compare all frequencies (130 Hz,
40 Hz, 80 Hz, 120 Hz, 160 Hz), with post-hoc test-
ing (Bonferroni correction and Tukey test) conducted
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RESULTS
Characteristics of the 20 participants are provided
in Table 1. All 20 participants completed the study,
but three participants could not tolerate 40 Hz due
to intolerable side effects, including worsening of
parkinsonism (particularly bradykinesia and tremor)
and oscillopsia. The results for both experimental
tasks along with statistical significance are presented
in Table 2.
Regarding the PP, there was a significant difference
in the Assembly PP task, but not in the Simple PP task.
Post-hoc testing showed that 80 Hz produced a sig-
nificantly higher score for the Assembly PP task over
the baseline (130 Hz) frequency (p = 0.007) and 40 Hz
(p = 0.04), but this was not reproduced in comparisons
with 120 Hz or 160 Hz. In comparison, the Tremor
and Rigidity scores for the UL-UPDRS-III reduced
significantly with higher experimental frequencies,
but there was no significant difference between fre-
quencies for Bradykinesia or Total Score. Post-hoc
Table 1
Characteristics of study participants
Participant Characteristic (n = 20) Mean (±SD)
Age (years) 60.4 ± 10.0
Sex 15 male, 5 female
Handedness 20 right, 0 left
PD Duration (years) 11.8 ± 4.9
Duration of DBS therapy (years) 2.5 ± 3.0
Levodopa equivalent dose (mg/day) 702.4 ± 304.4
UPDRS-III (ON-stimulation/ 15.6 ± 8.6
ON-medication)
MMSE 28.9 ± 1.5
FAB 16.9 ± 1.4
UPDRS-III, Unified Parkinson’s Disease Rating Scale, Motor
Subesection; MMSE, Mini-Mental State Exam; FAB, Frontal
Assessment Battery.
testing showed that 40 Hz gave significantly higher
Tremor and Rigidity scores, driving the overall sig-
nificance for these parameters.
DISCUSSION
In this experimental study, we found no con-
sistent effect of frequency on bradykinesia in the
acute setting using two different approaches to mea-
surement. Our modified version of the UPDRS did
not reveal a difference between high and low fre-
quencies; this contrasts with two earlier comparable
studies, which suggested that high frequencies, par-
ticularly those ≥130 Hz, are significantly better for
reducing bradykinesia [4, 11]. However, another
single-blinded study also investigated the effect of
frequency on bradykinesia in 6 PD patients and found
no significant difference across a range of 0–250 Hz
on bradykinesia [12]. These three studies all used a
smaller number of patients than in the present study,
and in two of the three studies the TEED was not
kept constant, therefore introducing a huge variabil-
ity in the total current delivered to each participant
[4, 11, 12].
Furthermore, our study found a significant
difference in Assembly PP task performance
between 80 Hz and baseline (130 Hz), whilst 120 Hz
and 160 Hz produced an improved—though non-
significant—performance. This suggests a similar
benefit at these frequencies on the increased pha-
sic alertness and divided attention required on the
Assembly PP task over the Simple PP task [13].
As expected, we found that tremor but also rigidity
were significantly better controlled at higher frequen-
cies, which has been demonstrated previously [3, 4].
Inspecting the post-hoc comparisons, only 40 Hz was
Table 2
Upper limb motor function according to various frequencies tested
DBS Frequency (Hz) p-value
Baseline [130] 40 Hz 80 Hz 120 Hz 160 Hz
Mean Left Hand 8.1 ± 0.6 7.5 ± 0.8 7.8 ± 0.7 8.4 ± 0.7 8.4 ± 0.5 0.15
Simple Right Hand 9.7 ± 0.4 9.1 ± 0.8 10.1 ± 0.6 9.7 ± 0.5 10.0 ± 0.6 0.32
PP Score Both Hands 6.1 ± 0.6 6.1 ± 0.6 6.7 ± 0.6 6.1 ± 0.6 6.1 ± 0.5 0.22
Assembly PP Score 1.9 ± 0.1 1.9 ± 0.2 2.3 ± 0.2 2.2 ± 0.2 2.1 ± 0.2 0.0191
Mean UL-UPDRS Bradykinesia (0–24) 7.6 ± 0.9 9.2 ± 1.6 8.3 ± 1.3 9.4 ± 1.1 8.3 ± 1.1 0.69
-III score Tremor (0–12) 0.8 ± 0.3 2.0 ± 0.5 1.0 ± 0.3 0.4 ± 0.2 0.4 ± 0.2 <0.0012
Rigidity (0–12) 3.2 ± 0.5 4.7 ± 0.7 3.4 ± 0.6 2.9 ± 0.4 3.4 ± 0.5 0.0293
Total (0–48) 11.60 ± 1.40 15.8 ± 2.4 12.7 ± 1.9 12.7 ± 1.4 12.0 ± 1.4 0.37
PP, Purdue Pegboard; UL-UPDRS-III, Upper Limb Unified Parkinson’s Disease Rating Scale, Motor Subsection. All values are mean ± SD.
P-values are given for comparisons between all experimental frequencies, with details of post-hoc testing given for significant comparisons.
1There was a significant difference between 80 Hz and 40 Hz (0.34, 95% CI –0.04–0.73; p = 0.04) and between 80 Hz and 130 Hz (0.35,
95% CI: 0.13–0.57; p = 0.007). 2There were significant differences between 40 Hz and all other experimental frequencies. 3There was a
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associated with significantly higher UL-UPDRS-III
scores; indeed, three patients could not complete the
experimental tasks whilst on 40 Hz. This resulted
from a mixture of parkinsonism caused by the low
frequency state and (what appears clinically to be)
capsular side effects from the higher voltage required
to maintain a constant TEED. Hence, 40 Hz clearly
appears to be unsuitable for use in clinical practice.
Comparatively, patients on 80 Hz DBS experienced
effects akin to the higher frequency states in the acute
setting. Therefore, categorising frequencies as ‘LFS’
or ‘HFS’ using a 100 Hz threshold may be misleading
as this does not always correlate to clinical efficacy.
Although the precise mechanism of DBS is
debated [14, 15], our findings support the theory that
HFS DBS overrides pathological low frequency beta
oscillatory activity (11 Hz-30 Hz) and establishes a
more regular firing pattern at a higher prokinetic
gamma frequency (>60 Hz) in dopaminergic path-
ways for symptoms such as bradykinesia and rigidity;
simultaneously, in the low-frequency oscillations of
tremor pathways, HFS may hold neurons in a refrac-
tory state and thus help alleviate tremor [16].
It is important to consider several limitations to
our study. Firstly, 20 patients were selected for the
study, and only 17 could tolerate all experimental
frequencies. Although this is the largest study of its
kind [4, 11, 12], it is likely to be still underpow-
ered to detect subtle differences. Secondly, it may
be argued that the interval between changing exper-
imental frequencies (10 minutes) is too short. This
strategy was applied as such for several reasons:
1) to ensure that residual effects of the preceding
frequency do not influence performance at subse-
quent frequencies, due to cumulative patient fatigue.
Temperli and colleagues reported that 75% of the
worsening of the UPDRS-III scores occurred from
15 minutes onwards after STN-DBS is ‘switched
off’ [17], whilst Krack and colleagues suggested that
when STN-DBS is switched on, the full effect on
motor function usually occurs within a few seconds,
though this can be variable [8]. This suggests that the
majority of our findings would have remained consis-
tent with a longer time interval. 2) It is challenging
to expose patients to longer between-trial intervals
as they attended the study in an off medication state.
3) Our randomisation strategy was designed in order
to mitigate any repetition effect and carry over effect.
Thirdly, to assess the clinical applicability of our find-
ings, a study assessing whether these experimental
frequencies can have a comparable chronic sustain-
able effect as compared to baseline over a longer time
period should be conducted, perhaps also assessing
the effect of frequency (especially LFS) on other PD
symptoms. These assessments were beyond the scope
of this acute study.
Moreover, though there has been debate about
the usefulness of the TEED [18], we decided to
keep the TEED constant in our study. In our experi-
ence, patients who benefited from a lower frequency
also had a higher voltage programmed according to
TEED. This experience was also shared by others, as
described by Zibetti and colleagues in a retrospective
study on LFS [19]. However, this phenomenon is not
universal, and the reasons why some patients do not
benefit are not well understood and require further
investigation.
A clear strength of this study was its randomized
double-blind design, which minimised several pos-
sible confounding factors. Each participant served
as their own control, with their performance in the
experimental frequencies compared to their baseline
score, thus age and sex differences, practice effect and
fatigue between participants on task performance was
minimised.
In conclusion, there was no significant differ-
ence between different frequencies of STN-DBS on
upper-limb bradykinesia in PD when tested acutely,
suggesting that a wider range of frequencies could
be used to tackle bradykinesia providing total elec-
trical energy delivered is maintained. Although HFS
appears better for tremor control, 80 Hz may be an
option in well-selected patients without the risk of
worsening bradykinesia, particularly if gait, swallow
or speech problems coexist. Further studies focus-
ing on longer-term follow-up assessing an expanded
range of PD symptoms at these frequencies are
warranted in order to demonstrate the clinical appli-
cability of these findings.
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